Twelve cases of drug-induced blepharospasm improved within 2 months of psychotropic cessation
Authors:
Open Access
- 1 June 2011
- journal article
- Published by Taylor & Francis in Drug, Healthcare and Patient Safety
- Vol. 3, 9-14
Abstract
Peer reviewed article authored by (Emoto Y, Emoto H, Oishi E, Hikita S, Wakakura M). Read article or submit your manuscript for publishing.Keywords
This publication has 11 references indexed in Scilit:
- Decreased dopamine D2receptor binding in essential blepharospasmActa Neurologica Scandinavica, 2008
- Update on blepharospasmNeurology, 2008
- Venlafaxine and tardive blepharospasm: A case reportProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2007
- Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesiaCochrane Database of Systematic Reviews, 2006
- Health-Related Quality of Life and Psychosocial Characteristics of Patients With Benign Essential BlepharospasmArchives of Ophthalmology (1950), 2006
- Etizolam and benzodiazepine induced blepharospasmJournal of Neurology, Neurosurgery & Psychiatry, 2004
- BlepharospasmNeurology, 2002
- Tardive blepharospasmMovement Disorders, 1998
- Drug-Associated Facial Dyskinesias???A Study of 238 PatientsJournal of Neuro-Ophthalmology, 1998
- Tardive Syndromes and Other Drug-Induced Movement DisordersClinical Neuropharmacology, 1995